NASDAQ : MGRX
Mangoceuticals, Inc. — Financial statements
Healthcare · Health Information Services · United States
Last price 0.2543 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.65M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Mangoceuticals, Inc. (MGRX) reported revenue of 315.23K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 315.23K | 456.02K | 615.87K | 731.49K | 8.94K | |
| Cost of Revenue | 143.64K | 205.63K | 235.91K | 299.99K | 4.09K | |
| Gross Profit | 171.59K | 250.39K | 379.96K | 431.50K | 4.85K | |
| Selling, General & Admin | 3.84M | 5.93M | 5.54M | 6.39M | 2.00M | 70.08K |
| Amortization of Goodwill & Intangibles | 1.12M | 1.12M | 721.53K | |||
| Operating Expenses | 13.33M | 17.84M | 8.62M | 8.55M | 2.00M | 70.08K |
| Operating Income | -13.16M | -17.59M | -8.24M | -8.12M | -1.99M | -70.08K |
| Interest Expense | -652.22K | -103.51K | -13.70K | -6.47K | -724.00 | |
| Interest & Investment Income | 6.47K | |||||
| Other Non Operating Income (Expenses) | -36.21K | -1.56M | -453.75K | -1.10M | ||
| EBT Excluding Unusual Items | -13.84M | -19.26M | -8.71M | -9.21M | -2.00M | -70.80K |
| Asset Writedown | -1.24M | -1.24M | ||||
| Legal Settlements | 1.00 | -125.62K | ||||
| Other Unusual Items | -19.39K | -19.39K | ||||
| Pretax Income | -15.10M | -20.64M | -8.71M | -9.21M | -2.00M | -70.80K |
| Earnings From Continuing Operations | -15.10M | -20.64M | -8.71M | -9.21M | -2.00M | -70.80K |
| Minority Interest in Earnings | 630.00 | 461.00 | 1.08K | |||
| Net Income | -15.10M | -20.64M | -8.71M | -9.21M | -2.00M | -70.80K |
| Preferred Dividends & Other Adjustments | 1.18M | 1.18M | 802.11K | |||
| Net Income to Common | -16.28M | -21.82M | -9.51M | -9.21M | -2.00M | -70.80K |
| Shares Outstanding (Basic) | 14.83M | 10.07M | 1.98M | 1.07M | 719.87K | 533.33K |
| Shares Outstanding (Diluted) | 14.83M | 10.07M | 1.98M | 1.07M | 719.87K | 533.33K |
| EPS (Basic) | -1.10 | -2.17 | -4.80 | -8.58 | -2.78 | |
| EPS (Diluted) | -1.10 | -2.17 | -4.80 | -8.58 | -2.78 | |
| Free Cash Flow | -3.89M | -5.85M | -4.86M | -7.00M | -1.39M | -70.08K |
| Free Cash Flow Per Share | -0.26 | -0.58 | -2.46 | -6.52 | -1.93 | -0.13 |
| Gross Margin | 54.43% | 54.91% | 61.70% | 58.99% | 54.26% | |
| Operating Margin | -4,173.65% | -3,858.11% | -1,337.90% | -1,109.84% | -22,279.70% | |
| Profit Margin | -5,164.40% | -4,784.65% | -1,543.87% | -1,259.40% | -22,352.11% | |
| Free Cash Flow Margin | -1,234.31% | -1,282.89% | -789.74% | -957.07% | -15,545.59% | |
| EBITDA | -12.10M | -15.87M | -7.51M | -8.09M | -1.99M | |
| D&A For EBITDA | 1.06M | 1.72M | 731.47K | 24.89K | 3.86K | |
| EBIT | -13.16M | -17.59M | -8.24M | -8.12M | -1.99M | -70.08K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 228.69K | 1.49M | 58.65K | 739.01K | 682.86K | 22.55K |
| Cash & Short-Term Investments | 228.69K | 1.49M | 58.65K | 739.01K | 682.86K | 22.55K |
| Inventory | 18.50K | |||||
| Prepaid Expenses | 42.00 | 7.14K | 11.74K | |||
| Other Current Assets | 16.96K | 53.95K | 16.94K | 77.89K | ||
| Total Current Assets | 245.69K | 1.55M | 75.59K | 835.40K | 694.61K | 22.55K |
| Property, Plant & Equipment | 280.54K | 309.65K | 182.12K | 215.39K | 291.74K | |
| Other Intangible Assets | 13.65M | 14.23M | 15.23M | |||
| Other Long-Term Assets | -119.82K | 16.94K | ||||
| Total Assets | 14.17M | 16.09M | 15.37M | 1.05M | 1.00M | 22.55K |
| Accounts Payable | 934.68K | 416.68K | 837.50K | 140.76K | 33.67K | |
| Accrued Expenses | 12.63K | 9.42K | 6.59K | 2.72K | ||
| Short-Term Debt | 150.00K | 167.46K | 39.27K | |||
| Current Portion of Leases | 28.30K | 307.82K | 64.96K | 63.72K | 56.73K | |
| Other Current Liabilities | 147.45K | 156.64K | 373.00K | |||
| Total Current Liabilities | 1.40M | 890.57K | 1.43M | 211.08K | 260.58K | 39.27K |
| Long-Term Leases | 250.91K | 64.96K | 128.68K | |||
| Total Liabilities | 1.65M | 890.57K | 1.43M | 276.04K | 389.26K | 39.27K |
| Common Stock | 1.80K | 1.59K | 325.00 | 148.00 | 1.34K | 800.00 |
| Additional Paid-In Capital | 57.57M | 55.52M | 34.79M | 12.00M | 2.63M | 181.00 |
| Retained Earnings | -45.36M | -40.65M | -20.00M | -11.23M | -2.02M | -17.70K |
| Comprehensive Income & Other | 319.09K | 321.53K | -835.56K | |||
| Total Common Equity | 12.53M | 15.20M | 13.95M | 774.75K | 614.03K | -16.72K |
| Minority Interest | -2.12K | -1.54K | -1.08K | |||
| Shareholders' Equity | 12.52M | 15.20M | 13.95M | 774.75K | 614.03K | -16.72K |
| Total Liabilities & Equity | 14.17M | 16.09M | 15.37M | 1.05M | 1.00M | 22.55K |
| Total Debt | 279.21K | 307.82K | 214.96K | 128.68K | 352.87K | 39.27K |
| Net Cash (Debt) | -50.52K | 1.18M | -156.31K | 610.33K | 330.00K | -16.72K |
| Net Cash Per Share | -0.00 | 0.12 | -0.08 | 0.57 | 0.46 | -0.03 |
| Filing Date Shares Outstanding | 21.57M | 16.97M | 5.17M | 1.53M | 891.00K | 533.33K |
| Total Common Shares Outstanding | 18.02M | 15.89M | 3.25M | 1.43M | 891.00K | 533.33K |
| Working Capital | -1.15M | 656.87K | -1.35M | 624.32K | 434.03K | -16.72K |
| Book Value Per Share | 0.70 | 0.96 | 4.30 | 0.54 | 0.69 | -0.03 |
| Tangible Book Value | -1.12M | 967.97K | -1.29M | 774.75K | 614.03K | -16.72K |
| Tangible Book Value Per Share | -0.06 | 0.06 | -0.40 | 0.54 | 0.69 | -0.03 |
| Machinery | 5.06K | 124.88K | 124.88K | 121.36K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -15.10M | -20.64M | -8.71M | -9.21M | -2.00M | -70.80K |
| Depreciation & Amortization | 1.06M | 1.72M | 731.47K | 24.89K | 3.86K | |
| Loss (Gain) From Sale of Assets | 18.39K | |||||
| Stock-Based Compensation | 8.44M | 11.88M | 2.35M | 2.16M | 774.15K | |
| Other Operating Activities | 209.71K | 213.09K | 77.19K | 48.51K | -145.35K | 724.00 |
| Change in Inventory | -18.50K | |||||
| Change in Accounts Payable | 98.23K | 55.67K | 696.74K | 107.09K | 33.67K | |
| Change in Other Net Operating Assets | 1.13M | 914.80K | -36.36K | -102.06K | -14.81K | |
| Operating Cash Flow | -3.89M | -5.85M | -4.86M | -7.00M | -1.35M | -70.08K |
| Capital Expenditures | -3.52K | -43.10K | ||||
| Sale of Property, Plant & Equipment | 65.00K | |||||
| Investing Cash Flow | 65.00K | -3.52K | -43.10K | |||
| Short-Term Debt Issued | 675.00K | 150.00K | 75.00K | |||
| Total Debt Issued | 119.94K | 675.00K | 150.00K | 75.00K | 157.08K | |
| Short-Term Debt Repaid | -206.50K | -167.46K | -25.07K | |||
| Total Debt Repaid | -206.50K | -206.50K | -167.46K | -25.07K | ||
| Net Debt Issued (Repaid) | -86.56K | 468.50K | 150.00K | -167.46K | 49.93K | 157.08K |
| Issuance of Common Stock | 4.11M | 6.70M | 1.33M | 7.22M | 2.00M | 3.20K |
| Financing Cash Flow | 4.02M | 7.27M | 4.13M | 7.06M | 2.05M | 160.28K |
| Foreign Exchange Rate Adjustments | -3.47K | 7.08K | -9.85K | |||
| Net Cash Flow | 127.67K | 1.43M | -680.35K | 56.15K | 660.31K | 90.20K |
| Free Cash Flow | -3.89M | -5.85M | -4.86M | -7.00M | -1.39M | -70.08K |
| Free Cash Flow Margin | -1,234.31% | -1,282.89% | -789.74% | -957.07% | -15,545.59% | |
| Free Cash Flow Per Share | -0.26 | -0.58 | -2.46 | -6.52 | -1.93 | -0.13 |
| Levered Free Cash Flow | 1.27M | 1.88M | -929.17K | -2.87M | -489.22K | |
| Unlevered Free Cash Flow | 1.68M | 1.94M | -920.60K | -2.87M | -485.18K | |
| Change in Working Capital | 1.50M | 970.47K | 660.38K | -13.47K | 18.87K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 5.17M | 11.39M | 6.20M | 5.83M | ||
| Enterprise Value | 5.22M | 11.02M | 6.39M | 4.73M | ||
| Last Close Price | 0.23 | 0.74 | 2.42 | 4.15 | ||
| PS Ratio | 16.71 | 24.97 | 10.06 | 7.96 | ||
| PB Ratio | 0.34 | 0.75 | 0.45 | 7.52 | ||
| P/TBV Ratio | 11.77 | 7.52 | ||||
| EV/Sales Ratio | 16.87 | 24.16 | 10.38 | 6.47 | ||
| Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.17 | 0.57 | -2.35 |
| Net Debt / Equity Ratio | 0.00 | -0.08 | 0.01 | -0.79 | -0.54 | -1.00 |
| Net Debt / EBITDA Ratio | -0.00 | 0.07 | -0.02 | 0.07 | 0.17 | |
| Net Debt / FCF Ratio | -0.01 | 0.20 | -0.03 | 0.09 | 0.24 | -0.24 |
| Asset Turnover | 0.02 | 0.03 | 0.07 | 0.71 | 0.02 | |
| Quick Ratio | 0.16 | 1.67 | 0.04 | 3.50 | 2.62 | 0.57 |
| Current Ratio | 0.18 | 1.74 | 0.05 | 3.96 | 2.67 | 0.57 |
| Return on Equity (ROE) | -95.10% | -141.66% | -118.31% | -1,326.69% | -669.02% | |
| Return on Assets (ROA) | -46.97% | -69.91% | -62.72% | -494.04% | -242.68% | |
| Return on Capital Employed (ROCE) | -103.00% | -115.80% | -59.10% | -966.80% | -268.20% | 419.10% |
| Earnings Yield | -471.70% | -181.27% | -140.45% | -158.13% | ||
| FCF Yield | -73.87% | -51.37% | -78.46% | -120.17% | ||
| Buyback Yield / Dilution | -208.91% | -408.93% | -84.23% | -49.22% | -34.98% |